Mycobacterial Shikimate Pathway Enzymes as Targets for Drug Design

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|8|3|423-435

ISSN： 1389-4501

Source： Current Drug Targets, Vol.8, Iss.3, 2007-01, pp. : 423-435

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New tuberculosis drug development: targeting the shikimate pathway

By Kapnick Senta M   Zhang Ying  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 5, 2008-05 ,pp. : 565-577

Informa Healthcare

Access to resources Recommend Favorite

Drug Targets in Mycobacterial Sulfur Metabolism

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 7, Iss. 2, 2007-06 ,pp. : 140-158

Bentham Science Publishers

Access to resources Recommend Favorite

Shikimate Kinase, a Protein Target for Drug Design

By  

Current Medicinal Chemistry, Vol. 21, Iss. 5, 2014-02 ,pp. : 592-604

Bentham Science Publishers

Access to resources Recommend Favorite

NAD(P) Biosynthesis Enzymes as Potential Targets for Selective Drug Design

By  

Current Medicinal Chemistry, Vol. 16, Iss. 11, 2009-04 ,pp. : 1372-1390

Bentham Science Publishers

Access to resources Recommend Favorite

The Interfaces of Oligomeric Proteins as Targets for Drug Design against Enzymes from Parasites

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 5, 2002-05 ,pp. : 457-470

Bentham Science Publishers

Access to resources Recommend Favorite